Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Arcus Biosciences, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 209
- +21 vs. Q3 2025
- Shares held
- 121.4M
- +21.0M (+21.0%) vs. Q3 2025
- Total value
- $2.89B
- +$1.53B (+112.0%) vs. Q3 2025
- New holders
- 48
- 95 more added
- Sold out
- 27
- 38 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 231 | $3.78B |
| Q1 2026 | 211 | $2.57B |
| Q4 2025 | 209 | $2.89B |
| Q3 2025 | 190 | $1.37B |
| Q2 2025 | 186 | $811.5M |
| Q1 2025 | 187 | $763.3M |
| Q4 2024 | 186 | $1.25B |
| Q3 2024 | 187 | $815.7M |
| Q2 2024 | 193 | $790.9M |
| Q1 2024 | 172 | $997.7M |
| Q4 2023 | 185 | $1.01B |
| Q3 2023 | 187 | $947.9M |
| Q2 2023 | 181 | $1.11B |
| Q1 2023 | 180 | $1.01B |
| Q4 2022 | 200 | $1.11B |
| Q3 2022 | 183 | $1.37B |
| Q2 2022 | 173 | $1.33B |
| Q1 2022 | 157 | $1.60B |
| Q4 2021 | 142 | $2.06B |
| Q3 2021 | 131 | $1.68B |
| Q2 2021 | 130 | $1.24B |
| Q1 2021 | 148 | $1.25B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Arcus Biosciences, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 3,280,000 | $78.2M | 0.12% | −1,052,479−24.3% | Reduced |
| Marshall Wace, LLP | 3,387,794 | $80.7M | 0.08% | +3,387,794 | New |
| Woodline Partners LP | 3,769,788 | $89.8M | 0.35% | +1040.0% | Added |
| State Street Corp | 4,576,969 | $109.1M | 0.00% | +1,182,115+34.8% | Added |
| Wellington Management Group LLP | 5,184,509 | $123.5M | 0.02% | +3,918,220+309.4% | Added |
| Suvretta Capital Management, LLC | 5,188,858 | $123.7M | 3.08% | +1,500,000+40.7% | Added |
| Vanguard Group Inc | 7,962,874 | $189.8M | 0.00% | +1,333,421+20.1% | Added |
| BlackRock, Inc. | 14,997,891 | $357.4M | 0.01% | +3,187,025+27.0% | Added |
| Gilead Sciences, Inc. | 31,424,760 | $748.9M | 38.69% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,136,364−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −379,100−100.0% | Sold out |
| Nordea Investment Management AB | 0 | $0 | 0.00% | −328,459−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −285,400−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −239,420−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −152,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −130,449−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −105,025−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −89,997−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −82,950−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −75,486−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −52,624−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −47,593−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −42,113−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −32,358−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −15,256−100.0% | Sold out |
| ISAM Funds (UK) Ltd | 0 | $0 | 0.00% | −13,959−100.0% | Sold out |
| Seelaus Asset Management LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Anfield Capital Management, LLC | 0 | $0 | 0.00% | −8,041−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −234−100.0% | Sold out |
| Halbert Hargrove Global Advisors, LLC | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| Atlantic Trust, LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Tortoise Investment Management, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| AXA Investment Managers S.A. | – | – | – | – | Not filed |
| Abich Financial Wealth Management LLC | – | – | – | – | Not filed |